Compounds > bicalutamide

bicalutamide and Experimental Mammary Neoplasms

bicalutamide has been researched along with Experimental Mammary Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maucher, A; von Angerer, E1
Darbre, PD; King, RJ1

Other Studies

2 other study(ies) available for bicalutamide and Experimental Mammary Neoplasms

ArticleYear
Antiproliferative activity of casodex (ICI 176.334) in hormone-dependent tumours.
    Journal of cancer research and clinical oncology, 1993, Volume: 119, Issue:11

    Topics: Androgen Antagonists; Anilides; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Diethylstilbestrol; Female; Flutamide; Male; Mammary Neoplasms, Experimental; Mice; Neoplasms, Hormone-Dependent; Nitriles; Prostatic Neoplasms; Rats; Rats, Inbred F344; Receptors, Androgen; Testosterone; Tosyl Compounds; Tumor Cells, Cultured

1993
Antiandrogen ICI 176,334 does not prevent development of androgen insensitivity in S115 mouse mammary tumour cells.
    Journal of steroid biochemistry, 1990, Aug-14, Volume: 36, Issue:5

    Topics: Androgen Antagonists; Anilides; Animals; Blotting, Northern; Cell Division; Cell Line; DNA, Neoplasm; Kinetics; Mammary Neoplasms, Experimental; Methylation; Mice; Nitriles; Restriction Mapping; RNA, Neoplasm; Testosterone; Tosyl Compounds

1990